In order to determine whether the observed decrease in ABA serum levels and altered expression of PPAR-γ and LANCL2 on PBMC are unique for COPD or would also apply for other chronic respiratory diseases, we analyzed the serum concentration of ABA in asthma patients and age- and gender-matched normal controls. The gene discussed is LANCL2; the disease is chronic obstructive pulmonary disease.